| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding study
|
Osowicki, Joshua
|
|
|
2 |
7 |
p. e291-e299
|
artikel
|
| 2 |
Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study
|
Corman, Victor M
|
|
|
2 |
7 |
p. e311-e319
|
artikel
|
| 3 |
Correction to Lancet Microbe 2021; 2: e331–41
|
|
|
|
2 |
7 |
p. e288
|
artikel
|
| 4 |
Correction to Lancet Microbe 2021; published online April 13. https://doi.org/10.1016/S2666-5247(21)00082-3
|
|
|
|
2 |
7 |
p. e288
|
artikel
|
| 5 |
Correction to Lancet Microbe 2021; published online April 20. https://doi.org/10.1016/S2666-5247(21)00069-0
|
|
|
|
2 |
7 |
p. e288
|
artikel
|
| 6 |
COVID-19 vaccination among Roma populations in Europe
|
Holt, Ed
|
|
|
2 |
7 |
p. e289
|
artikel
|
| 7 |
COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room
|
Olliaro, Piero
|
|
|
2 |
7 |
p. e279-e280
|
artikel
|
| 8 |
COVID-19 vaccines: effectiveness and number needed to treat
|
Correia, Luis C L
|
|
|
2 |
7 |
p. e281
|
artikel
|
| 9 |
COVID-19 vaccines: effectiveness and number needed to treat – Authors' reply
|
Olliaro, Piero
|
|
|
2 |
7 |
p. e282
|
artikel
|
| 10 |
Emergence and dissemination of antimicrobial resistance in Escherichia coli causing bloodstream infections in Norway in 2002–17: a nationwide, longitudinal, microbial population genomic study
|
Gladstone, Rebecca A
|
|
|
2 |
7 |
p. e331-e341
|
artikel
|
| 11 |
G7 leaders commit to greater pandemic preparedness (again)
|
The Lancet Microbe,
|
|
|
2 |
7 |
p. e276
|
artikel
|
| 12 |
Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis
|
Ramsheh, Mohammadali Yavari
|
|
|
2 |
7 |
p. e300-e310
|
artikel
|
| 13 |
Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study
|
Zürcher, Kathrin
|
|
|
2 |
7 |
p. e320-e330
|
artikel
|
| 14 |
Rapid tests for quantification of infectiousness are urgently required in patients with COVID-19
|
Pan, Daniel
|
|
|
2 |
7 |
p. e286-e287
|
artikel
|
| 15 |
SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
|
Jangra, Sonia
|
|
|
2 |
7 |
p. e283-e284
|
artikel
|
| 16 |
Serum sample neutralisation of BBIBP-CorV and ZF2001 vaccines to SARS-CoV-2 501Y.V2
|
Huang, Baoying
|
|
|
2 |
7 |
p. e285
|
artikel
|
| 17 |
Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?
|
McBride, Angela
|
|
|
2 |
7 |
p. e277-e278
|
artikel
|
| 18 |
WHO–Germany collaboration for pandemic intelligence research
|
Balakrishnan, Vijay Shankar
|
|
|
2 |
7 |
p. e290
|
artikel
|
Tijdschrift beschrijving